A study in healthy men to test whether carbamazepine influences the amount of nerandomilast in the blood

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521279-30-00

Acronym

1305-0119

Enrollment

Registered

2025-06-26

Start date

2025-08-06

Completion date

2025-10-01

Last updated

2025-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer trial

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026